Correction to: Leukemia advance online publication, 14 March 2017; doi: 10.1038/leu.2017.72
Following the publication of this article, the authors noted that Dr S-H Kim should have been noted as an equally contributing co-first author.
Additional information
The online version of the original article can be found at 10.1038/leu.2017.72
Rights and permissions
About this article
Cite this article
Han, S., Kim, SH., Kim, HJ. et al. Erratum: Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia. Leukemia 31, 1659 (2017). https://doi.org/10.1038/leu.2017.107
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2017.107
This article is cited by
-
FAM167A is a key molecule to induce BCR-ABL-independent TKI resistance in CML via noncanonical NF-κB signaling activation
Journal of Experimental & Clinical Cancer Research (2022)
-
Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B
Oncogene (2021)
